VVVeerasamy Vinothkumar

Veerasamy Vinothkumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Veerasamy Vinothkumar has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Sukumar Babukumar

    Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University , Annamalainagar , India

    7 shared publications
  • Subramani Srinivasan

    Department of Biochemistry, Government Arts College for Women, Krishnagiri, Tamil Nadu, India; Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu, India

    6 shared publications
  • Duraisamy Ramachandhiran

    Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University , Annamalainagar , India

    5 shared publications
  • Ramachandhiran Duraisamy

    5 shared publications
  • Shanmugam Manoharan

    Annamalai University

    4 shared publications
  • Dhananjayan Indumathi

    A Department of Biochemistry and Biotechnology, Faculty of Science , Annamalai University , Annamalainagar , Tamilnadu , India

    3 shared publications

Latest Publications

  • Exploring betanin regulatory impact on TGF-β and PI3K/AKT pathways in oral cancer

    by Ramachandhiran Duraisamy, Vinothkumar Veerasamy, Vaitheeswari Balakrishnan, Saranya Jawaharlal

  • Hesperidin Methyl Chalcone Inhibits Hallmarks of Cancer by Targeting the AKT, PI3K/GSK‐3β/β‐Catenin/STAT3 Signaling Axis in Oral Squamous Cell Carcinoma Models

    by Saranya Jawaharlal, Ramachandhiran Duraisamy, Vinothkumar Veerasamy

    Oral squamous cell carcinoma (OSCC) is the most prevalent and drug‐resistant cancer. We studied the chemopreventive effects of Hesperidin Methyl Chalcone (HMC) on DMBA‐induced hamster buccal pouch carcinogenesis (HBPCs). Male golden Syrian hamsters developed oral tumors on their left buccal pouches after being treated with 0.5% DMBA topically three times a week for 10 weeks. These findings suggest that well‐developed squamous cell carcinomas were highly differentiated, exhibiting hyperplasia and dysplasia. Hamsters with DMBA‐painted buccal mucosal tissue were treated with HMC, which greatly improved the biochemical and histological changes. In addition, in silico analysis was performed to anticipate possible protein targets for this medication, including Akt, Pi3k, GSk‐3β, β‐catenin, and STAT3. HMC has a high binding affinity to the above proteins. The current study reveals that HMC has strong chemopreventive properties and protects the Akt, Pi3k, GSk‐3β, β‐catenin, and STAT3 proteins, which were considerably changed during DMBA‐induced oral carcinogenesis.

  • Exploring anticancer potential of betanin in DMBA-induced oral squamous cell carcinoma: an in silico and experimental study

    by Ramachandhiran Duraisamy, Vinothkumar Veerasamy, Vaitheeswari Balakrishnan, Saranya Jawaharlal, Srinivasan Subramani, Vigil Anbiah Sathiavakoo

    In addition to being able to fight cancer, betanin (BTN) has amazing natural antioxidant and peroxy-radical scavenging properties. 7,12-Dimethylbenz[a]anthracene (DMBA) can impair the activities of enzymes accountable for breaking down xenobiotics and can also cause lipid peroxidation. The study’s goal was to find out if betanin could protect against these problems. We determined 100% tumor incidence, abnormal tumor volume, inclined tumor burden, and deduced body weight in DMBA-induced hamsters. We observed diminished lipid peroxidation and enzymatic and nonenzymatic antioxidant activities in DMBA-induced hamsters. The histological study showed that the hamster that receives only DMBA undergoes hyperkeratosis, epithelial hyperplasia, dysplasia, and well-differentiated oral squamous cell carcinoma (OSCC). The hamsters received three different dosages of BTN (10, 20, and 40 mg/kg b.w.) via intragastric intubation for 14 weeks, on alternate days of DMBA painting. The levels of antioxidants, xenobiotic enzymes, and lipid peroxidation (LPO) were significantly restored and inhibited tumor development in a dose-dependent manner. The molecular docking study found high levels of binding affinity in Bax (PDB ID: 2K7W), Caspase-3 (PDB ID: 4JJ8), Caspase-9 (PDB ID: 2AR9), PI3K (PDB ID: 5XGI), AKT (PDB ID: 6BUU), p53 (PDB ID: 1YCS), SMAD-2 (PDB ID: 1DEV), SMAD-4 (PDB ID: 1YGS), SMAD-7 (PDB ID: 2DJY), TGFβ-I (PDB ID: 1PY5), and TGFβ-II (PDB ID: 1M9Z). So, therefore, in vivo and in silico studies were providing prominent anticancer activity of betanin against DMBA-induced oral cancer.


  • Therapeutic Potential of Honey Against Hepatotoxicity and Renal Toxicity: Insight into Its Mechanisms of Action

    by Subramani Srinivasan, Raju Murali, Veerasamy Vinothkumar, Devarajan Raajasubramanian, Kuppan Narendra, Natarajan Ashokkumar, Palanisamy Selvaraj


  • Cyclodextrin‐based nanosponges as promising carriers for active pharmaceutical ingredient

    by Saranya Jawaharlal, Selvamuthukumar Subramanian, Venkatesan Palanivel, Geetha Devarajan, Vinothkumar Veerasamy

    Effective drug distribution at the intended or particular location is a critical issue that researchers are now dealing. Nanosponges have significantly increased in importance in medication delivery using nanotechnology in recent years. An important step toward solving these problems has been the development of nanosponges. Recently created and proposed for use in drug delivery, nanosponge is a unique type of hyper‐crosslinked polymer‐based colloidal structures made up of solid nanoparticles with colloidal carriers. Nanosponges are solid porous particles that may hold pharmaceuticals and other actives in their nanocavities. They can be made into dosage forms for oral, parenteral, topical, or inhalation use. The targeted distribution of drugs in a regulated manner is greatly aided by nanosponge. The utilization of nanosponges, their benefits, their production processes, the polymers they are made of, and their characterization have all been covered in this review article.


  • Cross-Linked β-Cyclodextrin Based Nanosponges for Allyl Methyl Sulfide Delivery-Physicochemical Characterization and In Vitro Study

    by Saranya Jawaharlal, Selvamuthukumar Subramanian, Venkatesan Palanivel, Geetha Devarajan, Ramachandhiran Duraisamy, Vaitheeswari Balakrishnan, Vinothkumar Veerasamy


  • Nerolidol assists Cisplatin to induce early apoptosis in human laryngeal carcinoma Hep 2 cells through ROS and mitochondrial‐mediated pathway: An in vitro and in silico view

    by Vaitheeswari Balakrishnan, Sindhu Ganapathy, Vinothkumar Veerasamy, Ramachandhiran Duraisamy, Saranya Jawaharlal, Vennila Lakshmanan

    The objective of this study was to examine Nerolidol (NER) and Cisplatin (CIS) performed against human laryngeal carcinoma (Hep 2) cells. We evaluated the effect of NER, CIS, and NER + CIS on cell viability, cell migration, oxidative stress, mitochondrial membrane depolarization, nuclear condensation, apoptotic induction, and DNA damage in Hep 2 cells. We used the MTT assay to assess the cytotoxicity effect of NER and CIS on Hep 2 cells in terms of morphological alterations. Present results demonstrated that IC50 values of NER and CIS have potential cytotoxicity against Hep 2 cells. NER effectively inhibited cell viability, increased reactive oxygen species generation, apoptotic induction, and DNA damage in Hep 2 cells. In addition, the docking study evaluated the structural binding interaction of NER with PI3K/Akt and PCNA protein. Furthermore, NER with PI3K/Akt, PCNA has a higher crucial score and affinity. Present results infer that NER could be used to target signaling molecules in anticancer studies. PRACTICAL APPLICATIONS: Nerolidol is a dietary phytochemical with high biological activity that can find in a variety of plants. Many researchers focused on Nerolidol to treat various diseases including cancer. However, there is no studies exist on laryngeal cancer. This study uses Nerolidol and Cisplatin to generate oxidative stress and stimulate apoptosis and DNA damage in human laryngeal cancer cells. Based on present findings, Nerolidol could be a choice of anticancer medication, either alone or in combination against oral squamous cell carcinomas in both in vitro and in vivo experimental systems.


  • Anticancer and antioxidant profiling effects of Nerolidol against DMBA induced oral experimental carcinogenesis

    by Vaitheeswari Balakrishnan, Sindhu Ganapathy, Vinothkumar Veerasamy, Ramachandhiran Duraisamy, Vigil Anbiah Sathiavakoo, Vasudevan Krishnamoorthy, Vennila Lakshmanan

    The objective of this study is to examine the chemopreventive effects of Nerolidol (NER) on hamster buccal pouch carcinogenesis (HBC) induced by 7,12‐dimethylbenz(a)anthracene (DMBA) in male golden Syrian hamsters. In this study, oral squamous cell carcinoma was developed in the buccal pouch of an oral painted hamster with 0.5% DMBA in liquid paraffin three times weekly for 12 weeks. To assess DMBA‐induced hamster buccal tissue carcinogenesis, biochemical endpoints such as Phase I and II detoxification enzymes, antioxidants, lipid peroxidation (LPO) by‐products, and renal function markers, as well as histopathological examinations, were used. Furthermore, the immunohistochemical studies of interleukin‐6 were investigated to find the inflammatory link in the HBC carcinogenesis. In our results, DMBA alone exposed hamsters showed 100% tumor growth, altered levels of antioxidants, detoxification agents, LPO, and renal function identifiers as compared to the control hamsters. The outcome in present biochemical, histopathological, and immunohistochemistry studies has been found a reverse in NER‐treated hamsters against the tumor. This study concluded that NER modulated the biochemical profiles (antioxidants, detoxification, LPO, and renal function markers) and inhibited tumor development in DMBA induced oral carcinogenesis.


  • β-Caryophyllene promotes oxidative stress and apoptosis in KB cells through activation of mitochondrial-mediated pathway – An in-vitro and in-silico study

    by Duraisamy Ramachandhiran, Chandrasekaran Sankaranarayanan, Raju Murali, Sukumar Babukumar, Veerasamy Vinothkumar

    Beta-caryophyllene (BCP), are natural bicyclic sesquiterpenes which are present in numerous plants worldwide. BCP has antioxidant, antimicrobial, and antifungal properties. Here, we studied its anticancer, anti-inflammatory, and cytotoxic effects. Cells treated with BCP, in a dose-dependent manner, exhibited morphological changes, showed lower cell growth, underwent apoptosis and lost the ability to metastasis through the suppression of NF-ҡ B via PI3K/AKT signalling pathway. These results elucidate that the inhibition of NF-ҡ B and PI3K/AKT is one of the most important mechanism by which BCP suppresses cancer cell proliferation and enhances apoptosis.


  • Modulating effect of hesperetin on the molecular expression pattern of apoptotic and cell proliferative markers in 7,12-dimethylbenz(a)anthracene-induced oral carcinogenesis

    by Sukumar Babukumar, Veerasamy Vinothkumar, Duraisamy Ramachandhiran

    Oral squamous cell carcinoma (OSCC) is widespread malignant neoplasm and refractory cancers in worldwide. Here, we studied the chemopreventive potential of hesperetin on 7,12-dimethylbenz(a)anthracene (DMBA)-induced hamster buccal pouch carcinogenesis (HBPCs). Oral tumours were developed in the buccal pouches of male golden Syrian hamsters by topical application of 0.5% DMBA three times a week for 10 weeks. This causes sequentially hyperplasia, dysplasia and well differentiates squamous cell carcinoma (SCC) with up-regulation of molecular markers like mutant-p53, Caspase-3 and caspase-9 and cyclin-D1. Histology, immunohistochemistry (IHC), real time PCR (qRT-PCR) and western blot analysis of hesperetin treated animals shows a reversal in the above expression pattern to near normal in buccal mucosal tissue. Therefore, hesperetin exhibits the potential protective effect against DMBA-induced oral cancer through apoptotic and anti-proliferative properties. However, a long-term observation would be needed to confirm the possibility of malignant change of the resulted dysplastic lesions upon hesperetin pretreatment.